Immunotherapy of Guillain-Barré syndrome

Immunotherapy of Guillain-Barré syndrome

Guillain-Barré syndrome (GBS), the most common cause of acute neuromuscular weakness and paralysis worldwide, encompasses a group of acute immune-mediated disorders restricted to peripheral nerves and roots. Immune-mediated attack of peripheral nervous system myelin, axons or both is presumed to be...

Full description

Bibliographic Details
Main Authors: Shuang Liu, Chaoling Dong, Eroboghene Ekamereno Ubogu
Format: Article
Language:English
Published: Taylor & Francis Group 2018-11-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
blood-nerve barrier
guillain-barré syndrome
leukocyte trafficking
immunopathology
immunotherapy
peripheral nerve inflammation
Online Access:http://dx.doi.org/10.1080/21645515.2018.1493415

Internet

http://dx.doi.org/10.1080/21645515.2018.1493415

Similar Items